Development of a Standardized Susceptibility Test for Campylobacter with Quality-Control Ranges for Ciprofloxacin, Doxycycline, Erythromycin, Gentamicin, and Meropenem

Authors:

Abstract
A standardized agar dilution susceptibility testing method was developed for Campylobacter that consisted of testing on Mueller–Hinton medium supplemented with 5% defibrinated sheep blood in an atmosphere of 10% CO 2 , 5% O 2 , and 85% N 2 . Campylobacter jejuni ATCC 33560 was identified as a quality-control (QC) strain. Minimal inhibitory concentration (MIC) QC ranges were determined for two incubation time/temperature combinations: 36°C for 48 hr and 42°C for 24 hr. Quality-control ranges were determined for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. For all antimicrobial agents tested at both temperatures, 95–100% of the QC MIC results fell within recommended QC ranges. Twenty-one Campylobacter clinical isolates, encompassing five species of Campylobacter ( C. jejuni , C. coli , C. jejuni , subsp. doylei , C. fetus , and C. lari ) were tested in conjunction with the C. jejuni QC strain. While C. jejuni and C. coli could be reliably tested under both test conditions, growth of C. jejuni subsp. doylei , C. fetus , and C. lari isolates was inconsistent when incubated at 42°C. Therefore, it is recommended that these species only be tested at 36°C.

This publication has 15 references indexed in Scilit: